News World UK hospital told to prepare for Oxford COVID vaccine in November

UK hospital told to prepare for Oxford COVID vaccine in November

Staff at a major London hospital trust have been told to be ready to receive the first batches of the vaccine being developed by the University of Oxford and AstraZeneca Plc, The Sun newspaper reported on Monday.

The Sun said the hospital was told to prepare for the vaccine from the “week commencing the 2nd of November.”

In the meantime, the vaccine being developed by the University of Oxford and AstraZeneca Plc produces a robust immune response in elderly people, the group at highest risk, the Financial Times said on Monday.

The vaccine triggers protective antibodies and T-cells in older age groups, the FT said, citing two people familiar with the finding, encouraging researchers as they seek evidence that it will spare those in later life from serious illness or death from the virus.

Details of the finding are expected to be published shortly in a clinical journal, the FT said, without naming the publication.

The findings echo data released in July which showed the vaccine generated “robust immune responses” in a group of healthy adults aged between 18 and 55, the newspaper reported, citing people aware of the results from so-called immunogenicity blood tests.

But the FT cautioned that positive immunogenicity tests do not guarantee that the vaccine will ultimately prove safe and effective in older people.

AstraZeneca, which is developing the vaccine with Oxford University researchers, is seen as a frontrunner in the race to produce a vaccine to protect against COVID-19.

Oxford and AstraZeneca did not immediately respond to Reuters’ request for comments.

One of the world’s leading coronavirus vaccine candidates, called AZD1222 or ChAdOx1 nCoV-19, was developed by Oxford University scientists and licensed to AstraZeneca in April, which took on the task of scaling trials and production.

AstraZeneca resumed the U.S. trial of the experimental vaccine after approval by U.S. regulators, the company said on Friday.

It is a viral vector vaccine that uses a weakened version of a chimpanzee common cold virus that encodes instructions for making proteins from the novel coronavirus to build immunity against COVID-19.

(Reuters)

Top Stories

New covid cases under 200 today, number of hospitalised rising

  The health ministry announced 152 new cases of covid-19 over the past 24 hours, 11 of which were confirmed by PCR following an initial...

Central Bank Governor tests positive for covid

  Central Bank governor Constandinos Herodotou has tested positive for covid-19 and will self-isolate at home where he will continue his duties. Herodotou announced the positive...

Britain expects “very significant” week for Brexit talks as clock ticks down

  Britain and the European Union are heading into a “very significant” week, British foreign minister Dominic Raab said, as talks over a trade deal...

No restrictions to and from Limassol and Paphos as of midnight

  Authorities are suspending movement restrictions to and from Limassol and Paphos as of midnight in line with the new health ministry directives announced on...

Iran to give a ‘calculated’ response to nuclear scientist killing, says official

  Iran will give a “calculated and decisive” response to the killing of its top nuclear scientist, said a top adviser to Iran’s supreme leader,...

Taste

Squash soup

Ingredients: 1 kg pumpkin, cut into small cubes, approximately 5 cups 2 medium (400g) sweet potatoes, cut into cubes, approximately 2 ½ cups 1 chopped leek, only...

Mezedes

No visit to Cyprus is complete without enjoying the traditional meal of many small dishes known as ‘meze’. This large feast, which has been a...

Prawns with fried cheese, barley shaped pasta

Put the barley shaped pasta into a small pan with salted water, bring to a boil and when tender, drain. Peal the prawns leaving...

Salmon and shrimp sheftalies

Mix all ingredients for tabbouli in a bowl and keep to one side so flavours can combine. Prepare the sheftalies: wash and soak the casing...